It may differ from company to company based on dif
Post# of 148160
“ Aug. 20, 2020 4:40 PM ETGlobeNewswireMedicenna Therapeutics Corp. (MDNAF)1 Comment
GlobeNewswire
TORONTO and HOUSTON, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (MDNAF) ("Medicenna" or the "Company" (Nasdaq: MDNA) (TSX: MDNA), a clinical stage immuno-oncology company, today announced that the Company’s common shares have been approved for listing on The Nasdaq Capital Market (“Nasdaq”). Trading is expected to begin on Monday, August 24, 2020, under the symbol “MDNA” on the Nasdaq. The Corporation will retain its listing on the Toronto Stock Exchange under the symbol "MDNA" and the Company's common shares will continue to trade on the OTCQB under the symbol "MDNAF" until trading on the Nasdaq commences.”